α1A-Adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion

Molecular Pharmacology

Volumn 83, Issue 5, 2013, Pages 939-948

  Papay, Robert S ^a   Shi, Ting ^a   Piascik, Michael T ^b   Prasad, Sathyamangla V Naga ^a   Perez, Dianne M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ATRIAL NATRIURETIC FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROPRANOLOL; STAT3 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CARDIOMEGALY; KNOCKOUT MOUSE; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; CARDIOMEGALY; INTERLEUKIN-6; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCYTES, CARDIAC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION;

EID: 84876536966     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.084483     Document Type: Article

References (57)

1. Autelitano DJ and Woodcock EA (1998) Selective activation of a1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of a1-adrenergic receptor subtype mRNAs. J Mol Cell Cardiol 30:1515-1523. (Pubitemid 28418642)
2. Butler KL, Huffman LC, Koch SE, Hahn HS, and Gwathmey JK (2006) STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium. Am J Physiol Heart Circ Physiol 291:H797-H803. (Pubitemid 44175087)
3. Cavalli A, Lattion AL, Hummler E, Nenniger M, Pedrazzini T, Aubert JF, Michel MC, Yang M, Lembo G, and Vecchione C et al. (1997) Decreased blood pressure response in mice deficient of the a1b-adrenergic receptor. Proc Natl Acad Sci USA 94:11589-11594.
4. Clerk A, Michael A, and Sugden PH (1998) Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G proteincoupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy? J Cell Biol 142:523-535. (Pubitemid 28361557)
5. Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG, and Kobilka BK (1988) Molecular cloning and expression of the cDNA for the hamster a 1-adrenergic receptor. Proc Natl Acad Sci USA 85:7159-7163.
6. Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, and Glembotski CC (2000) p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 275: 23814-23824. (Pubitemid 30624667)
7. Faber JE, Yang N, and Xin X (2001) Expression of a-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 298:441-452. (Pubitemid 32673393)
8. Gibson RM, Laszlo GS, and Nathanson NM (2005) Calmodulin-dependent protein kinases phosphorylate gp130 at the serine-based dileucine internalization motif. Biochim Biophys Acta 1714:56-62. (Pubitemid 41039230)
9. Gonzalez-Cabrera PJ, Gaivin RJ, Yun J, Ross SA, Papay RS, McCune DF, Rorabaugh BR, and Perez DM (2003) Genetic profiling of a 1-adrenergic receptor subtypes by oligonucleotide microarrays: Coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130. Mol Pharmacol 63:1104-1116. (Pubitemid 36529929)
10. Grisanti LA, Woster AP, Dahlman J, Sauter ER, Combs CK, and Porter JE (2011) a1-adrenergic receptors positively regulate Toll-like receptor cytokine production from human monocytes and macrophages. J Pharmacol Exp Ther 338:648-657.
11. Grupp IL, Lorenz JN, Walsh RA, Boivin GP, and Rindt H (1998) Overexpression of a1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am J Physiol 275:H1338-H1350.
12. Hague C, Lee SE, Chen Z, Prinster SC, Hall RA, and Minneman KP (2006) Heterodimers of a1B-and a1D-adrenergic receptors form a single functional entity. Mol Pharmacol 69:45-55. (Pubitemid 43048892)
13. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, Hillmer A, Schmiedl A, Ding Z, and Podewski E et al. (2004) Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95:187-195. (Pubitemid 38988685)
14. Hirasawa A, Tsumaya K, Awaji T, Shibata K, Homma N, Shinomiya T, and Tsujimoto G (1996) Flow cytometry analysis of a1-adrenoceptor subtypes. FEBS Lett 386: 141-148. (Pubitemid 26170136)
15. Hirota H, Yoshida K, Kishimoto T, and Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92: 4862-4866.
16. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, and Ueno H et al. (2002) Involvement of nuclear factorkappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105:509-515. (Pubitemid 34141710)
17. Jacoby JJ, Kalinowski A, Liu MG, Zhang SS, Gao Q, Chai GX, Ji L, Iwamoto Y, Li E, and Schneider M et al. (2003) Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci USA 100:12929-12934. (Pubitemid 37340002)
18. Jensen BC, O'Connell TD, and Simpson PC (2011) a-1-adrenergic receptors: Targets for agonist drugs to treat heart failure. J Mol Cell Cardiol 51:518-528.
19. Jensen BC, Swigart PM, Montgomery MD, and Simpson PC (2010) Functional a-1B adrenergic receptors on human epicardial coronary artery endothelial cells. Naunyn Schmiedebergs Arch Pharmacol 382:475-482.
20. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700. (Pubitemid 29289066)
21. Jordan BA, Gomes I, Rios C, Filipovska J, and Devi LA (2003) Functional interactions between mu opioid and a 2A-adrenergic receptors. Mol Pharmacol 64: 1317-1324. (Pubitemid 37532221)
22. Knowlton KU, Michel MC, Itani M, Shubeita HE, Ishihara K, Brown JH, and Chien KR (1993) The a 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 268:15374-15380. (Pubitemid 23222024)
23. Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, and Kishimoto T (1996) Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation 94:2626-2632. (Pubitemid 26403595)
24. Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Yamada S, Okabe M, Kishimoto T, and Yamauchi-Takihara K (2000) Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA 97:315-319 (Pubitemid 30055828)
25. Lemire I, Ducharme A, Tardif JC, Poulin F, Jones LR, Allen BG, Hébert TE, and Rindt H (2001) Cardiac-directed overexpression of wild-type a1B-adrenergic receptor induces dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 281: H931-H938.
26. Lin F, Owens WA, Chen S, Stevens ME, Kesteven S, Arthur JF, Woodcock EA, Feneley MP, and Graham RM (2001) Targeted a(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res 89:343-350. (Pubitemid 34132673)
27. Loppnow H and Libby P (1990) Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 85:731-738. (Pubitemid 20087475)
28. McWhinney C, Wenham D, Kanwal S, Kalman V, Hansen C, and Robishaw JD (2000) Constitutively active mutants of the a(1a)-and the a(1b)-adrenergic receptor subtypes reveal coupling to different signaling pathways and physiological responses in rat cardiac myocytes. J Biol Chem 275:2087-2097. (Pubitemid 30060837)
29. Meier H, Bullinger J, Marx G, Deten A, Horn LC, Rassler B, Zimmer HG, and Briest W (2009) Crucial role of interleukin-6 in the development of norepinephrineinduced left ventricular remodeling in mice. Cell Physiol Biochem 23:327-334.
30. Michel MC, Hanft G, and Gross G (1994) Radioligand binding studies of a 1-adrenoceptor subtypes in rat heart. Br J Pharmacol 111:533-538. (Pubitemid 24146111)
31. Michel MC and Insel PA (1994) Comparison of cloned and pharmacologically defined rat tissue a 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 350: 136-142. (Pubitemid 24248371)
32. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, and Lefkowitz RJ (1994) Myocardial expression of a constitutively active a 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 91: 10109-10113.
33. Mir SA, Chatterjee A, Mitra A, Pathak K, Mahata SK, and Sarkar S (2012) Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J Biol Chem 287:2666-2677.
34. Nemoto S, Sheng Z, and Lin A (1998) Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol 18: 3518-3526. (Pubitemid 28240524)
35. O'Connell TD, Rokosh DG, and Simpson PC (2001) Cloning and characterization of the mouse a1C/A-adrenergic receptor gene and analysis of an a1C promoter in cardiac myocytes: Role of an MCAT element that binds transcriptional enhancer factor-1 (TEF-1). Mol Pharmacol 59:1225-1234. (Pubitemid 32381602)
36. O'Connell TD, Swigart PM, Rodrigo MC, Ishizaka S, Joho S, Turnbull L, Tecott LH, Baker AJ, Foster E, and Grossman W et al. (2006) a1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J Clin Invest 116:1005-1015.
37. Perez DM and Doze VA (2011) Cardiac and neuroprotection regulated by a(1)-adrenergic receptor subtypes. J Recept Signal Transduct Res 31:98-110.
38. Perez DM, Papay RS, and Shi T (2009) alpha1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: Involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Mol Pharmacol 76:144-152.
39. Perez DM, Piascik MT, and Graham RM (1991) Solution-phase library screening for the identification of rare clones: Isolation of an a 1D-adrenergic receptor cDNA. Mol Pharmacol 40:876-883.
40. Perez DM, Piascik MT, Malik N, and Gaivin RJ, andGraham RM (1994) Cloning, expression, and tissue distribution of the rat homolog of the bovine a 1C-adrenergic receptor provide evidence for its classification as the a 1A subtype. Mol Pharmacol 46:823-831.
41. Rediger A, Piechowski CL, Yi CX, Tarnow P, Strotmann R, Grüters A, Krude H, Schöneberg T, Tschöp MH, and Kleinau G et al. (2011) Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J Biol Chem 286:39623-39631.
42. Ritchie RH, Rosenkranz AC, and Kaye DM (2009) B-type natriuretic peptide: Endogenous regulator of myocardial structure, biomarker and therapeutic target. Curr Mol Med 9:814-825.
43. Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA, Long CS, and Simpson PC (1996) a1-adrenergic receptor subtype mRNAs are differentially regulated by a1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of a1B and a1D but induction of a1C. J Biol Chem 271:5839-5843.
44. Rorabaugh BR, Ross SA, Gaivin RJ, Papay RS, McCune DF, Simpson PC, and Perez DM (2005) a1A-but not a1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism. Cardiovasc Res 65:436-445. (Pubitemid 40082486)
45. Selvetella G, Hirsch E, Notte A, Tarone G, and Lembo G (2004) Adaptive and maladaptive hypertrophic pathways: Points of convergence and divergence. Cardiovasc Res 63:373-380. (Pubitemid 38970181)
46. Shi T, Papay RS, and Perez DM (2012) a(1A)-adrenergic receptor differentially regulates STAT3 phosphorylation through PKCe and PKCd in myocytes. J Recept Signal Transduct Res 32:76-86.
47. Simpson P (1983) Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an a 1 adrenergic response. J Clin Invest 72:732-738. (Pubitemid 13051335)
48. Spotnitz HM and Sonnenblick EH (1973) Structural conditions in the hypertrophied and failing heart. Am J Cardiol 32:398-406.
49. Stanasila L, Perez JB, Vogel H, and Cotecchia S (2003) Oligomerization of the a 1aand a 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J Biol Chem 278:40239-40251. (Pubitemid 37248592)
50. Tayebati SK, Bronzetti E, Morra Di Cella S, Mulatero P, Ricci A, Rossodivita I, Schena M, Schiavone D, Veglio F, and Amenta F (2000) In situ hybridization and immunocytochemistry of a1-adrenoceptors in human peripheral blood lymphocytes. J Auton Pharmacol 20:305-312. (Pubitemid 34205836)
51. Wang BH, Du XJ, Autelitano DJ, Milano CA, and Woodcock EA (2000) Adverse effects of constitutively active a(1B)-adrenergic receptors after pressure overload in mouse hearts. Am J Physiol Heart Circ Physiol 279:H1079-H1086.
52. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, and Kishimoto T (1995) Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91:1520-1524.
53. Yun J, Zuscik MJ, Gonzalez-Cabrera P, McCune DF, Ross SA, Gaivin R, Piascik MT, and Perez DM (2003) Gene expression profiling of a(1b)-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays. Cardiovasc Res 57:443-455. (Pubitemid 36144223)
54. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, and Glembotski CC (1997) A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 139:115-127. (Pubitemid 27444085)
55. Zuscik MJ, Chalothorn D, Hellard D, Deighan C, McGee A, Daly CJ, Waugh DJJ, Ross SA, Gaivin RJ, and Morehead AJ et al. (2001) Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the a 1B-adrenergic receptor. J Biol Chem 276:13738-13743.
56. Zuscik MJ, Piascik MT, and Perez DM (1999) Cloning, cell-type specificity, and regulatory function of the mouse a(1B)-adrenergic receptor promoter. Mol Pharmacol 56:1288-1297.
57. Zuscik MJ, Sands S, Ross SA, Waugh DJJ, Gaivin RJ, Morilak D, and Perez DM (2000) Overexpression of the a1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy. Nat Med 6:1388-1394. (Pubitemid 32001024)